Epify BV is rated 3 out of 5 in the category biotechnology. Read and write reviews about Epify BV. Epify develops epigenetic biomarkers which control gene activity and are implicated in a wide range of cancers, driving and influencing the development of the disease. Using these biomarkers, Epify aims to drive earlier detection and more accurate diagnosis, facilitating personalized oncology and better outcomes for cancer patients.
Company size
1-10 employees
Headquarters
Maastricht, Limburg